Semiconductors
Compare Stocks
5 / 10Stock Comparison
AEHR vs COHU vs ACLS vs ONTO vs ICHR
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
AEHR vs COHU vs ACLS vs ONTO vs ICHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Semiconductors | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $2.96B | $2.33B | $5.54B | $14.63B | $2.52B |
| Revenue (TTM) | $49M | $481M | $839M | $1.03B | $959M |
| Net Income (TTM) | $-11M | $-56M | $120M | $106M | $-51M |
| Gross Margin | 30.2% | 25.7% | 44.9% | 48.8% | 11.3% |
| Operating Margin | -27.8% | -10.6% | 14.2% | 10.0% | -3.8% |
| Forward P/E | — | 93.2x | 46.9x | 41.6x | 63.4x |
| Total Debt | $11M | $359M | $42M | $17M | $186M |
| Cash & Equiv. | $25M | $227M | $145M | $346M | $98M |
AEHR vs COHU vs ACLS vs ONTO vs ICHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Aehr Test Systems (AEHR) | 100 | 5862.4 | +5762.4% |
| Cohu, Inc. (COHU) | 100 | 329.5 | +229.5% |
| Axcelis Technologie… (ACLS) | 100 | 636.9 | +536.9% |
| Onto Innovation Inc. (ONTO) | 100 | 946.1 | +846.1% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 318.7 | +218.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: AEHR vs COHU vs ACLS vs ONTO vs ICHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
AEHR is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 69.6% 10Y total return vs ACLS's 16.1%
- +10.8% vs ONTO's +140.2%
COHU ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 0 yrs, beta 2.13
- Rev growth 12.7%, EPS growth -6.7%, 3Y rev CAGR -17.7%
- Beta 2.13, current ratio 6.88x
- 12.7% revenue growth vs AEHR's -20.2%
ACLS carries the broadest edge in this set and is the clearest fit for sleep-well-at-night.
- Lower volatility, beta 2.00, Low D/E 4.1%, current ratio 4.77x
- 14.3% margin vs AEHR's -22.7%
- Beta 2.00 vs AEHR's 4.77, lower leverage
- 8.8% ROA vs AEHR's -7.5%, ROIC 9.6% vs -3.0%
ONTO is the clearest fit if your priority is valuation efficiency.
- PEG 1.20 vs ACLS's 2.22
- Lower P/E (41.6x vs 63.4x)
Among these 5 stocks, ICHR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.7% revenue growth vs AEHR's -20.2% | |
| Value | Lower P/E (41.6x vs 63.4x) | |
| Quality / Margins | 14.3% margin vs AEHR's -22.7% | |
| Stability / Safety | Beta 2.00 vs AEHR's 4.77, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +10.8% vs ONTO's +140.2% | |
| Efficiency (ROA) | 8.8% ROA vs AEHR's -7.5%, ROIC 9.6% vs -3.0% |
AEHR vs COHU vs ACLS vs ONTO vs ICHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
AEHR vs COHU vs ACLS vs ONTO vs ICHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ACLS leads in 2 of 6 categories
AEHR leads 1 • ICHR leads 1 • COHU leads 0 • ONTO leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — COHU and ACLS and ONTO each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ONTO is the larger business by revenue, generating $1.0B annually — 21.0x AEHR's $49M. ACLS is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to AEHR's -22.7%. On growth, COHU holds the edge at +29.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $49M | $481M | $839M | $1.0B | $959M |
| EBITDAEarnings before interest/tax | -$10M | -$11M | $137M | $158M | -$11M |
| Net IncomeAfter-tax profit | -$11M | -$56M | $120M | $106M | -$51M |
| Free Cash FlowCash after capex | -$14M | $32M | $107M | $239M | -$17M |
| Gross MarginGross profit ÷ Revenue | +30.2% | +25.7% | +44.9% | +48.8% | +11.3% |
| Operating MarginEBIT ÷ Revenue | -27.8% | -10.6% | +14.2% | +10.0% | -3.8% |
| Net MarginNet income ÷ Revenue | -22.7% | -11.5% | +14.3% | +10.3% | -5.3% |
| FCF MarginFCF ÷ Revenue | -28.1% | +6.6% | +12.8% | +23.2% | -1.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | -26.5% | +29.3% | -5.6% | +9.5% | +4.7% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.2% | +60.6% | -28.6% | -48.5% | +46.2% |
Valuation Metrics
Evenly matched — ACLS and ONTO each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 45.0x trailing earnings, ACLS trades at a 57% valuation discount to ONTO's 105.8x P/E. Adjusting for growth (PEG ratio), ACLS offers better value at 2.13x vs ONTO's 3.06x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $3.0B | $2.3B | $5.5B | $14.6B | $2.5B |
| Enterprise ValueMkt cap + debt − cash | $2.9B | $2.5B | $5.4B | $14.3B | $2.6B |
| Trailing P/EPrice ÷ TTM EPS | -744.08x | -31.21x | 45.00x | 105.77x | -47.08x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 93.24x | 46.87x | 41.57x | 63.37x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.13x | 3.06x | — |
| EV / EBITDAEnterprise value multiple | — | — | 39.71x | 73.94x | — |
| Price / SalesMarket cap ÷ Revenue | 50.23x | 5.15x | 6.60x | 14.55x | 2.66x |
| Price / BookPrice ÷ Book value/share | 23.29x | 2.95x | 5.23x | 6.90x | 3.74x |
| Price / FCFMarket cap ÷ FCF | — | 217.20x | 51.77x | 48.79x | — |
Profitability & Efficiency
ACLS leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
ACLS delivers a 11.6% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-8 for AEHR. ONTO carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to COHU's 0.46x. On the Piotroski fundamental quality scale (0–9), ACLS scores 5/9 vs AEHR's 1/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -8.5% | -6.8% | +11.6% | +5.2% | -7.5% |
| ROA (TTM)Return on assets | -7.5% | -4.9% | +8.8% | +4.7% | -5.2% |
| ROICReturn on invested capital | -3.0% | -5.7% | +9.6% | +5.7% | -3.9% |
| ROCEReturn on capital employed | -3.2% | -5.9% | +10.4% | +6.5% | -4.7% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 4 | 5 | 4 | 3 |
| Debt / EquityFinancial leverage | 0.09x | 0.46x | 0.04x | 0.01x | 0.28x |
| Net DebtTotal debt minus cash | -$14M | $132M | -$103M | -$329M | $87M |
| Cash & Equiv.Liquid assets | $25M | $227M | $145M | $346M | $98M |
| Total DebtShort + long-term debt | $11M | $359M | $42M | $17M | $186M |
| Interest CoverageEBIT ÷ Interest expense | — | -168.82x | 33.79x | — | -5.97x |
Total Returns (Dividends Reinvested)
AEHR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AEHR five years ago would be worth $429,911 today (with dividends reinvested), compared to $13,141 for COHU. Over the past 12 months, AEHR leads with a +1081.1% total return vs ONTO's +140.2%. The 3-year compound annual growth rate (CAGR) favors AEHR at 53.7% vs ACLS's 12.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +336.5% | +101.6% | +98.6% | +77.3% | +255.3% |
| 1-Year ReturnPast 12 months | +1081.1% | +217.9% | +212.7% | +140.2% | +353.2% |
| 3-Year ReturnCumulative with dividends | +262.8% | +47.0% | +42.5% | +241.3% | +155.6% |
| 5-Year ReturnCumulative with dividends | +4199.1% | +31.4% | +324.6% | +359.0% | +33.8% |
| 10-Year ReturnCumulative with dividends | +6960.6% | +345.2% | +1610.0% | +1558.5% | +642.2% |
| CAGR (3Y)Annualised 3-year return | +53.7% | +13.7% | +12.5% | +50.6% | +36.7% |
Risk & Volatility
ACLS leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ACLS is the less volatile stock with a 2.00 beta — it tends to amplify market swings less than AEHR's 4.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ACLS currently trades 99.7% from its 52-week high vs ONTO's 93.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 4.77x | 2.13x | 2.00x | 2.66x | 3.93x |
| 52-Week HighHighest price in past year | $102.48 | $50.68 | $171.60 | $315.86 | $72.87 |
| 52-Week LowLowest price in past year | $8.02 | $15.34 | $52.55 | $85.88 | $13.12 |
| % of 52W HighCurrent price vs 52-week peak | +94.4% | +97.9% | +99.7% | +93.1% | +99.5% |
| RSI (14)Momentum oscillator 0–100 | 64.3 | 73.7 | 71.7 | 67.5 | 61.4 |
| Avg Volume (50D)Average daily shares traded | 3.0M | 935K | 717K | 831K | 795K |
Analyst Outlook
ICHR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AEHR as "Hold", COHU as "Buy", ACLS as "Buy", ONTO as "Buy", ICHR as "Buy". Consensus price targets imply 4.9% upside for ONTO (target: $308) vs -35.9% for AEHR (target: $62).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $62.00 | $49.75 | $128.00 | $308.33 | $49.80 |
| # AnalystsCovering analysts | 3 | 14 | 12 | 11 | 14 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | 0 | 0 | — | 1 |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.0% | +0.3% | +2.2% | +0.5% | 0.0% |
ACLS leads in 2 of 6 categories (Profitability & Efficiency, Risk & Volatility). AEHR leads in 1 (Total Returns). 2 tied.
AEHR vs COHU vs ACLS vs ONTO vs ICHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is AEHR or COHU or ACLS or ONTO or ICHR a better buy right now?
For growth investors, Cohu, Inc.
(COHU) is the stronger pick with 12. 7% revenue growth year-over-year, versus -17. 6% for Axcelis Technologies, Inc. (ACLS). Axcelis Technologies, Inc. (ACLS) offers the better valuation at 45. 0x trailing P/E (46. 9x forward), making it the more compelling value choice. Analysts rate Cohu, Inc. (COHU) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — AEHR or COHU or ACLS or ONTO or ICHR?
On trailing P/E, Axcelis Technologies, Inc.
(ACLS) is the cheapest at 45. 0x versus Onto Innovation Inc. at 105. 8x. On forward P/E, Onto Innovation Inc. is actually cheaper at 41. 6x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Onto Innovation Inc. wins at 1. 20x versus Axcelis Technologies, Inc. 's 2. 22x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — AEHR or COHU or ACLS or ONTO or ICHR?
Over the past 5 years, Aehr Test Systems (AEHR) delivered a total return of +42.
0%, compared to +31. 4% for Cohu, Inc. (COHU). Over 10 years, the gap is even starker: AEHR returned +69. 6% versus COHU's +345. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — AEHR or COHU or ACLS or ONTO or ICHR?
By beta (market sensitivity over 5 years), Axcelis Technologies, Inc.
(ACLS) is the lower-risk stock at 2. 00β versus Aehr Test Systems's 4. 77β — meaning AEHR is approximately 139% more volatile than ACLS relative to the S&P 500. On balance sheet safety, Onto Innovation Inc. (ONTO) carries a lower debt/equity ratio of 1% versus 46% for Cohu, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — AEHR or COHU or ACLS or ONTO or ICHR?
By revenue growth (latest reported year), Cohu, Inc.
(COHU) is pulling ahead at 12. 7% versus -17. 6% for Axcelis Technologies, Inc. (ACLS). On earnings-per-share growth, the picture is similar: Aehr Test Systems grew EPS 0. 0% year-over-year, compared to -140. 6% for Ichor Holdings, Ltd.. Over a 3-year CAGR, AEHR leads at 5. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — AEHR or COHU or ACLS or ONTO or ICHR?
Axcelis Technologies, Inc.
(ACLS) is the more profitable company, earning 14. 3% net margin versus -16. 4% for Cohu, Inc. — meaning it keeps 14. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACLS leads at 14. 2% versus -13. 3% for COHU. At the gross margin level — before operating expenses — ONTO leads at 49. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is AEHR or COHU or ACLS or ONTO or ICHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Onto Innovation Inc. (ONTO) is the more undervalued stock at a PEG of 1. 20x versus Axcelis Technologies, Inc. 's 2. 22x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Onto Innovation Inc. (ONTO) trades at 41. 6x forward P/E versus 93. 2x for Cohu, Inc. — 51. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ONTO: 4. 9% to $308. 33.
08Which pays a better dividend — AEHR or COHU or ACLS or ONTO or ICHR?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is AEHR or COHU or ACLS or ONTO or ICHR better for a retirement portfolio?
For long-horizon retirement investors, Axcelis Technologies, Inc.
(ACLS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+1610% 10Y return). Aehr Test Systems (AEHR) carries a higher beta of 4. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ACLS: +1610%, AEHR: +69. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between AEHR and COHU and ACLS and ONTO and ICHR?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.